{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:46:30Z","timestamp":1775349990768,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["rep.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nilotinib is a second-generation tyrosine kinase inhibitor (TKI) that is widely used to treat patients with Philadelphia chromosome-positive chronic myeloid leukaemia (CML). TKIs provided a significant improvement in terms of survival rates and disease-free period in CML; however, there is insufficient knowledge about their side effects, including reproductive toxicity. Since nearly half of the CML patients are in their reproductive age, and newly announced indications cover the treatment of the paediatric age groups, concerns arise about the effects of these drugs on the reproductive system, as there are no controlled preclinical studies. We investigated acute and long-term gonadotoxic and teratogenic effects of nilotinib, utilising a mouse model that simulates various clinical scenarios. We observed significant testicular damage in mice receiving nilotinib according to Johnsen\u2019s score analysis. Alterations were observed in female mice\u2019s number of follicles, as the primordial follicle numbers significantly decreased. Proliferating cell number in both genders\u2019 gonads decreased and apoptosis rate increased significantly. The nilotinib-received female and male mice\u2019s pregnancy rates were low compared to controls. A significant decrease in the thickness of the spongiotrophoblast and decidual layers of the placenta was detected in pregnancies consisting of male and\/or female mice treated with nilotinib. The results of this study establish a critical point of view for clinical translation and indicate the importance of consulting patients for directing them to fertility preservation and contraception options for both genders before nilotinib treatment.<\/jats:p>","DOI":"10.1530\/rep-20-0548","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T13:59:01Z","timestamp":1610373541000},"page":"295-306","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-11","source":"Crossref","is-referenced-by-count":7,"title":["Deleterious reproductive effects of nilotinib in mouse model"],"prefix":"10.1093","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4525-9027","authenticated-orcid":false,"given":"Sinan","family":"Ozkavukcu","sequence":"first","affiliation":[{"name":"Department of Histology and Embryology , Ankara University Faculty of Medicine, Ankara, Turkey"},{"name":"Center for Assisted Reproduction , Department of Obstetrics and Gynecology, Ankara University Faculty of Medicine, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilay","family":"Kuscu","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology , Akdeniz University Faculty of Medicine, Antalya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dileyra","family":"Adiguzel","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology , Akdeniz University Faculty of Medicine, Antalya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guldane","family":"Cengiz-Seval","sequence":"additional","affiliation":[{"name":"Department of Hematology , Ankara University Faculty of Medicine, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciler","family":"Celik-Ozenci","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology , Akdeniz University Faculty of Medicine, Antalya, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"2026010712052592300_bib1","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2014.028","article-title":"Tyrosine kinase inhibitors and pregnancy","volume":"6","author":"Abruzzese","year":"2014","journal-title":"Mediterranean Journal of Hematology and Infectious Diseases"},{"key":"2026010712052592300_bib2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/17474086.2016.1205479","article-title":"Management of pregnant chronic myeloid leukemia patients","volume":"9","author":"Abruzzese","year":"2016","journal-title":"Expert Review of Hematology"},{"key":"2026010712052592300_bib3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.leukres.2014.10.002","article-title":"Outcome of pregnancy in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors: short report from a single centre","volume":"39","author":"Alizadeh","year":"2015","journal-title":"Leukemia Research"},{"key":"2026010712052592300_bib4","first-page":"811","article-title":"Delivery of a healthy newborn by the partner of a patient with cml undergoing treatment with nilotinib","volume":"47","author":"Aota","year":"2020","journal-title":"Gan To Kagaku Ryoho: Cancer and Chemotherapy"},{"key":"2026010712052592300_bib5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.leukres.2011.01.021","article-title":"Nilotinib cardiac toxicity: should we still be concerned?","volume":"35","author":"Atallah","year":"2011","journal-title":"Leukemia Research"},{"key":"2026010712052592300_bib6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/1078155217692399","article-title":"Experience with dasatinib and nilotinib use in pregnancy","volume":"24","author":"Barkoulas","year":"2018","journal-title":"Journal of Oncology Pharmacy Practice"},{"key":"2026010712052592300_bib7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/CAD.0b013e328352a8fe","article-title":"A dramatic fetal outcome following transplacental transfer of dasatinib","volume":"23","author":"Berveiller","year":"2012","journal-title":"Anti-Cancer Drugs"},{"key":"2026010712052592300_bib8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00404-016-4262-z","article-title":"Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers","volume":"295","author":"Carlier","year":"2017","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"2026010712052592300_bib9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1530\/REP-09-0101","article-title":"Functions of tam rtks in regulating spermatogenesis and male fertility in mice","volume":"138","author":"Chen","year":"2009","journal-title":"Reproduction"},{"key":"2026010712052592300_bib10","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.21873\/anticanres.11265","article-title":"Teratogenic effect of radotinib: case report","volume":"36","author":"Cheon","year":"2016","journal-title":"Anticancer Research"},{"key":"2026010712052592300_bib11","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-42","article-title":"Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study","volume":"2","author":"Conchon","year":"2009","journal-title":"Journal of Hematology and Oncology"},{"key":"2026010712052592300_bib12","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0109","article-title":"Planned pregnancy in female patients with chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy","volume":"24","author":"Dou","year":"2019","journal-title":"Oncologist"},{"key":"2026010712052592300_bib13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12185-013-1398-5","article-title":"Nilotinib-induced interstitial lung disease","volume":"98","author":"Go","year":"2013","journal-title":"International Journal of Hematology"},{"key":"2026010712052592300_bib14","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1016\/j.fertnstert.2010.04.018","article-title":"Imatinib decreases endometrial stromal cell transmesothial migration and proliferation in the extracellular matrix of modeled peritoneum","volume":"94","author":"Griffith","year":"2010","journal-title":"Fertility and Sterility"},{"key":"2026010712052592300_bib15","doi-asserted-by":"publisher","first-page":"181560","DOI":"10.1155\/2012\/181560","article-title":"Protein-tyrosine kinase signaling in the biological functions associated with sperm","volume":"2012","author":"Ijiri","year":"2012","journal-title":"Journal of Signal Transduction"},{"key":"2026010712052592300_bib16","author":"Jensen","year":"2006","journal-title":"AMN107: Efficacy of the Selective Bcr-Abl Tyrosine Kinase Inhibitor in a Murine Model of Chronic Myelogenous Leukemia"},{"key":"2026010712052592300_bib17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000178170","article-title":"Testicular biopsy score count \u2013 a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males","volume":"1","author":"Johnsen","year":"1970","journal-title":"Hormones"},{"key":"2026010712052592300_bib18","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1002\/cncr.11831","article-title":"Imatinib mesylate therapy improves survival in patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data","volume":"98","author":"Kantarjian","year":"2003","journal-title":"Cancer"},{"key":"2026010712052592300_bib19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mrd.20456","article-title":"Tyrosine protein kinases and spermatogenesis: truncation matters","volume":"73","author":"Kierszenbaum","year":"2006","journal-title":"Molecular Reproduction and Development"},{"key":"2026010712052592300_bib20","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/mrd.21326","article-title":"Protein tyrosine kinase signaling during oocyte maturation and fertilization","volume":"78","author":"Mcginnis","year":"2011","journal-title":"Molecular Reproduction and Development"},{"key":"2026010712052592300_bib21","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1200\/JCO.2015.62.4718","article-title":"Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia","volume":"33","author":"Moslehi","year":"2015","journal-title":"Journal of Clinical Oncology"},{"key":"2026010712052592300_bib22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1365-2605.2007.00755.x","article-title":"Inhibition of tyrosine kinases pdgfr and c-kit by imatinib mesylate interferes with postnatal testicular development in the rat","volume":"30","author":"Nurmio","year":"2007","journal-title":"International Journal of Andrology"},{"key":"2026010712052592300_bib23","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1007\/s00277-015-2317-z","article-title":"Managing pregnancy in chronic myeloid leukaemia","volume":"94","author":"Palani","year":"2015","journal-title":"Annals of Hematology"},{"key":"2026010712052592300_bib24","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.clml.2017.07.005","article-title":"Cutaneous adverse events of targeted therapies for hematolymphoid malignancies","volume":"17","author":"Ransohoff","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2026010712052592300_bib25","author":"Ross","year":"2016","journal-title":"Histology: A Text and Atlas"},{"key":"2026010712052592300_bib26","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1182\/blood-2009-07-232595","article-title":"Nilotinib for the frontline treatment of ph(+) chronic myeloid leukemia","volume":"114","author":"Rosti","year":"2009","journal-title":"Blood"},{"key":"2026010712052592300_bib27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39134-0","article-title":"Imatinib treatments have long-term impact on placentation and embryo survival","volume":"9","author":"Salem","year":"2019","journal-title":"Scientific Reports"},{"key":"2026010712052592300_bib28","article-title":"Fda approves nilotinib for pediatric patients with newly diagnosed or resistant\/intolerant ph+ cml in chronic phase","year":"2018"},{"key":"2026010712052592300_bib29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcdb.2014.04.013","article-title":"Role of non-receptor protein tyrosine kinases in spermatid transport during spermatogenesis","volume":"30","author":"Wan","year":"2014","journal-title":"Seminars in Cell and Developmental Biology"},{"key":"2026010712052592300_bib30","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.apjtm.2015.06.001","article-title":"Effect of pdgf-rb antagonist imatinib on endometrial injury repairing in mouse model","volume":"8","author":"Wang","year":"2015","journal-title":"Asian Pacific Journal of Tropical Medicine"},{"key":"2026010712052592300_bib31","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3389\/fendo.2018.00570","article-title":"Regulation of placental development and its impact on fetal growth \u2013 new insights from mouse models","volume":"9","author":"Woods","year":"2018","journal-title":"Frontiers in Endocrinology"},{"key":"2026010712052592300_bib32","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.leukres.2013.07.020","article-title":"Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor","volume":"37","author":"Zhou","year":"2013","journal-title":"Leukemia Research"}],"container-title":["Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rep.bioscientifica.com\/view\/journals\/rep\/161\/3\/REP-20-0548.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/rep.bioscientifica.com\/downloadpdf\/journals\/rep\/161\/3\/REP-20-0548.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/reproduction\/article-pdf\/161\/3\/295\/64062841\/rep-20-0548.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/reproduction\/article-pdf\/161\/3\/295\/64062841\/rep-20-0548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T17:05:49Z","timestamp":1767805549000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/reproduction\/article\/161\/3\/295\/8216812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1530\/rep-20-0548","relation":{},"ISSN":["1470-1626","1741-7899"],"issn-type":[{"value":"1470-1626","type":"print"},{"value":"1741-7899","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2021,3,1]]}}}